Sinopharm Group Co. Ltd (X2S) — Financial Flexibility Index
Sinopharm Group Co. Ltd (X2S) has a Financial Flexibility Index of -0.01x as of June 2023. Free cash flow of €-2.32 Billion (operating CF €-2.63 Billion minus capex €312.96 Million) represents 0% of total liabilities (€304.58 Billion). Also explore how fast is Sinopharm Group Co. Ltd growing its equity to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Sinopharm Group Co. Ltd Financial Flexibility Index (2013–2025)
Historical Financial Flexibility Index trend for Sinopharm Group Co. Ltd across 13 annual periods. Check how strategically is Sinopharm Group Co. Ltd's equity deployed to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Sinopharm Group Co. Ltd (2013–2025)
Year-by-year free cash flow to debt coverage for Sinopharm Group Co. Ltd. For the full company profile including market capitalisation, see X2S company net worth.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.06x | €15.76 Billion | €14.14 Billion | €256.20 Billion | ▲ +21.1% |
| 2024 | 0.05x | €13.51 Billion | €11.55 Billion | €266.14 Billion | ▼ -31.5% |
| 2023 | 0.07x | €19.51 Billion | €17.17 Billion | €263.08 Billion | ▼ -18.2% |
| 2022 | 0.09x | €23.09 Billion | €20.96 Billion | €254.71 Billion | ▲ +87.8% |
| 2021 | 0.05x | €11.38 Billion | €9.31 Billion | €235.76 Billion | ▼ -18.1% |
| 2020 | 0.06x | €13.05 Billion | €11.15 Billion | €221.29 Billion | ▼ -45.8% |
| 2019 | 0.11x | €20.98 Billion | €18.78 Billion | €192.95 Billion | ▲ +164.2% |
| 2018 | 0.04x | €6.89 Billion | €3.65 Billion | €167.50 Billion | ▼ -8.7% |
| 2017 | 0.05x | €5.33 Billion | €3.21 Billion | €118.27 Billion | ▼ -52.0% |
| 2016 | 0.09x | €10.62 Billion | €9.26 Billion | €113.18 Billion | ▼ -35.9% |
| 2015 | 0.15x | €14.43 Billion | €13.41 Billion | €98.55 Billion | ▲ +92.9% |
| 2014 | 0.08x | €7.01 Billion | €5.56 Billion | €92.37 Billion | ▼ -3.9% |
| 2013 | 0.08x | €6.07 Billion | €4.94 Billion | €76.84 Billion | — |